2011 update of the drug resistance mutations in HIV-1

VA Johnson, V Calvez, HF Günthard… - Topics in antiviral …, 2016 - pmc.ncbi.nlm.nih.gov
The development of more recently approved drugs that cannot be tested as monotherapy
precludes assessment of the impact of resistance on antiretroviral activity that is not …

HIV drug resistance against strand transfer integrase inhibitors

K Anstett, B Brenner, T Mesplede, MA Wainberg - Retrovirology, 2017 - Springer
Integrase strand transfer inhibitors (INSTIs) are the newest class of antiretroviral drugs to be
approved for treatment and act by inhibiting the essential HIV protein integrase from …

Antiviral activity of bictegravir (GS-9883), a novel potent HIV-1 integrase strand transfer inhibitor with an improved resistance profile

M Tsiang, GS Jones, J Goldsmith… - Antimicrobial agents …, 2016 - Am Soc Microbiol
ABSTRACT Bictegravir (BIC; GS-9883), a novel, potent, once-daily, unboosted inhibitor of
HIV-1 integrase (IN), specifically targets IN strand transfer activity (50% inhibitory …

Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication

F Christ, A Voet, A Marchand, S Nicolet… - Nature chemical …, 2010 - nature.com
Lens epithelium–derived growth factor (LEDGF/p75) is a cellular cofactor of HIV-1 integrase
that promotes viral integration by tethering the preintegration complex to the chromatin. By …

[HTML][HTML] 2019 update of the drug resistance mutations in HIV-1

AM Wensing, V Calvez… - Topics in antiviral …, 2019 - ncbi.nlm.nih.gov
The 2019 edition of the IAS-USA drug resistance mutations list updates the Figure last
published in January 2017. The mutations listed are those that have been identified by …

[HTML][HTML] HIV-1 drug resistance mutations: an updated framework for the second decade of HAART

RW Shafer, JM Schapiro - AIDS reviews, 2008 - ncbi.nlm.nih.gov
More than 200 mutations are associated with antiretroviral resistance to drugs belonging to
six licensed antiretroviral classes. More than 50 reverse transcriptase mutations are …

2014 Update of the drug resistance mutations in HIV-1

AM Wensing, V Calvez, HF Günthard… - Topics in antiviral …, 2016 - pmc.ncbi.nlm.nih.gov
Methods The IAS–USA Drug Resistance Mutations Group is an independent, volunteer
panel of experts charged with delivering accurate, unbiased, and evidence-based …

Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments

L Menéndez-Arias - Antiviral research, 2013 - Elsevier
The introduction of potent combination therapies in the mid-90s had a tremendous effect on
AIDS mortality. However, drug resistance has been a major factor contributing to …

Integrase and integration: biochemical activities of HIV-1 integrase

O Delelis, K Carayon, A Saïb, E Deprez, JF Mouscadet - Retrovirology, 2008 - Springer
Integration of retroviral DNA is an obligatory step of retrovirus replication because proviral
DNA is the template for productive infection. Integrase, a retroviral enzyme, catalyses …

Development of antiretroviral drug resistance

MA Wainberg, GJ Zaharatos… - New England Journal of …, 2011 - Mass Medical Soc
Analysis of HIV drug resistance has identified sites on HIV target genes that convey
resistance to particular classes of agents. These data may be especially important in …